A carregar...
Serum bone markers and Risk of Osteoporosis and Fragility Fractures in Women Who Received Endocrine Therapy for Breast Cancer: A Prospective Study
PURPOSE: Osteoporosis and fragility fracture are major bone toxicities of aromatase inhibitors (AIs) for postmenopausal hormone receptor positive breast cancer. Except for a few small studies on bone turnover markers and reduced bone mineral density after AI treatment, data on the associations of bo...
Na minha lista:
| Publicado no: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7171589/ https://ncbi.nlm.nih.gov/pubmed/31912328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05518-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|